CEBPD and pancreatic ductal adenocarcinoma: Conversely, shRNA-dependent silencing of C/EBPδ enhances proliferation in a dose-dependent manner strongly suggesting that C/EBPδ expression levels negatively correlate with the proliferative capacity of pancreatic ductal adenocarcinoma cells.